The direct contribution of MDSCs to in vivo T cell suppression in T cell-mediated diseases has remained largely uninvestigated, although, recently, ARG1 has been shown to limit graft versus host disease (GVHD) in mice. The gene discussed is ARG1; the disease is graft versus host disease.